Structural and functional insight of New Delhi Metallo β-lactamase-1 variants

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Feng H, Ding J, Zhu D et al. Structural and mechanistic insights into NDM-1 catalyzed hydrolysis of cephalosporins. J. Am. Chem. Soc. 136(42), 14694–14697 (2014).
  Medline CASGoogle Scholar
• 2 Toleman MA, Bennett PM, Walsh TR. Common regions e.g. orf513 and antibiotic resistance: IS91-like elements evolving complex class 1 integrons. J. Antimicrob. Chemother. 58(1), 1–6 (2006).
  Medline CASGoogle Scholar
• 3 Saini A, Bansa R. Insights on the structural characteristics of NDM-1: the journey so far. Adv. Biol. Chem. 2, 323–334 (2012).
  CASGoogle Scholar
• 4 Wilke MS, Lovering AL, Strynadka NC. β-lactam antibiotic resistance: a current structural perspective. Curr. Opin. Microbiol. 8(5), 525–533 (2005).
  Medline CASGoogle Scholar
• 5 Chiou J, Leung TY, Chen S. Molecular mechanisms of substrate recognition and specificity of New Delhi metallo-β-lactamase. Antimicrob. Agents Chemother. 58(9), 5372–5378 (2014).
  MedlineGoogle Scholar
• 6 Kim Y, Cunningham MA, Mire J, Tesar C, Sacchettini J, Joachimiak A. NDM-1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism. FASEB J. 27(5), 1917–1927 (2013).
  Medline CASGoogle Scholar
• 7 Hammoudi D, Moubareck CA, Sarkis DK. How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. J. Microbiol. Methods 107, 106–118 (2014).
  Medline CASGoogle Scholar
• 8 Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20(3), 440–458 (2007).
  Medline CASGoogle Scholar
• 9 Yang H, Aitha M, Hetrick AM, Richmond TK, Tierney DL, Crowder MW. Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1. Biochemistry 51(18), 3839–3847 (2012).
  Medline CASGoogle Scholar
• 10 Kim Y, Tesar C, Mire J et al. Structure of apo- and monometalated forms of NDM-1 – a highly potent carbapenem-hydrolyzing metallo-β-lactamase. PLoS ONE 6, e24621 (2011). •• Gives a detailed insight of the crystal structure of NDM-1 and the important residues that make up the structure.
  Medline CASGoogle Scholar
• 11 Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol. 2(5), 501–512 (2007).
  Medline CASGoogle Scholar
• 12 Yong D, Toleman MA, Giske CG et al. Characterization of a new metallo-β-lactamase gene, blaNDM-1 and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53(12), 5046–5054 (2009). •• First reported and characterized blaNDM-1 gene.
  Medline CASGoogle Scholar
• 13 Galleni M, Lamotte-Brasseur J, Rossolini GM, Spencer J, Dideberg O, Frère JM. A standard numbering scheme for the Class A β-lactamases. Biochem. J. 276, 269–270 (1991).
  MedlineGoogle Scholar
• 14 Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39(6), 1211–1233 (1995).
  Medline CASGoogle Scholar
• 15 Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: a molecular, biological and epidemiological study. Lancet Infect. Dis. 10(9), 597–602 (2010).
  Medline CASGoogle Scholar
• 16 Bonnin RA, Poirel L, Carattoli A, Nordmann P. Characterization of an IncFII plasmid encoding NDM-1 from Escherichia coli ST131. PloS ONE 7, e34 752 (2012).
  CASGoogle Scholar
• 17 Lahey clinic. ß-lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. www.lahey.org/studies/.
  Google Scholar
• 18 Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 66(6), 1260–1262 (2011).
  Medline CASGoogle Scholar
• 19 Tada T, Miyoshi-Akiyama T, Shimada K, Kirikae T. Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob. Agents Chemother. 58(6), 3538–3540 (2014).
  MedlineGoogle Scholar
• 20 Nordmann P, Boulanger AE, Poirel L. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob. Agents Chemother. 56(4), 2184–2186 (2012).
  Medline CASGoogle Scholar
• 21 Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 55(12), 5952–5954 (2011).
  Medline CASGoogle Scholar
• 22 Williamson DA, Sidjabat HE, Freeman JT et al. Identification and molecular characterisation of New Delhi metallo-β-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int. J. Antimicrob. Agents 39(6), 529–533 (2012).
  Medline CASGoogle Scholar
• 23 Göttig S, Hamprecht AG, Christ S, Kempf VA, Wichelhaus TA. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity. J. Antimicrob. Chemother. 68(8), 1737–1740 (2013).
  MedlineGoogle Scholar
• 24 Tada T, Miyoshi-Akiyama T, Dahal RK et al. NDM-8 metallo-β-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrob. Agents Chemother. 57(5), 2394–2396 (2013).
  Medline CASGoogle Scholar
• 25 Wang X, Li H, Zhao C et al. Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China. Int. J. Antimicrob. Agents 44(1), 90–101 (2014).
  Medline CASGoogle Scholar
• 26 Khajuria A, Praharaj AK, Kumar M, Grover N. Presence of a novel variant NDM-10, of the New Delhi metallo-beta-lactamase in a Klebsiella pneumoniae isolate. Indian J. Med. Microbiol. 34(1), 121–123 (2016).
  MedlineGoogle Scholar
• 27 Khan AU, Ali A, Srivastava G, Sharma A. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multidrug-resistant bacteria. Sci. Rep. 7(1), 9207 (2017).
  MedlineGoogle Scholar
• 28 Tada T, Shrestha B, Miyoshi-Akiyama T et al. NDM-12, a novel New Delhi metallo-β-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal. Antimicrob. Agents Chemother. 58(10), 6302–6305 (2014).
  MedlineGoogle Scholar
• 29 Shrestha B, Tada T, Miyoshi-Akiyama T et al. Identification of a novel NDM variant, NDM-13, from a multidrug-resistant Escherichia coli clinical isolate in Nepal. Antimicrob. Agents Chemother. 59(9), 5847–5850 (2015).
  Medline CASGoogle Scholar
• 30 Zou D, Huang Y, Zhao X et al. A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese hospital possesses increased enzymatic activity against carbapenems. Antimicrob. Agents Chemother. 59(4), 2450–2453 (2015).
  Medline CASGoogle Scholar
• 31 Liu Z, Wang Y, Walsh TR et al. Plasmid-mediated novel blaNDM-17 gene encoding a carbapenemase with enhanced activity in a ST48 Escherichia coli strain. Antimicrob. Agents Chemother. 61(5), pii:AAC.02233–16 (2017).
  Google Scholar
• 32 Brown MC, Verma D, Russell C, Jacobs DJ, Livesay DR. A case study comparing quantitative stability–flexibility relationships across five metallo-β-lactamases highlighting differences within NDM-1. Methods Mol. Biol. 1084, 227–238 (2014).
  Medline CASGoogle Scholar
• 33 Khan AU, Nordmann P. NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India. J. Med. Microbiol. 61(Pt 3), 454–456 (2012).
  Medline CASGoogle Scholar
• 34 Zheng B, Tan S, Gao J et al. An unexpected similarity between antibiotic-resistant NDM-1 and β-lactamase II from Erythrobacter litoralis. Protein Cell 2(3), 250–258 (2011).
  Medline CASGoogle Scholar
• 35 Thomas PW, Zheng M, Wu S et al. Characterization of purified New Delhi metallo-β-lactamase-1. Biochemistry 50(46), 10102–10113 (2011). • Talks about the NDM-1's preference of substrates and the effect of zinc concentration on hydrolysis rates.
  Medline CASGoogle Scholar
• 36 Guo Y, Wang J, Niu G et al. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug. Protein Cell 2(5), 384–394 (2011).
  Medline CASGoogle Scholar
• 37 Bebrone C. Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem. Pharmacol. 74(12), 1686–1701 (2007).
  Medline CASGoogle Scholar
• 38 Zhang H, Hao Q. Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism. FASEB J. 25(8), 2574–2582 (2011). • The crystal structure of NDM-1 in complex with hydrolysed ampicillin at 1.3 Å resolution is presented here with the proposed mechanism of catalysis.
  Medline CASGoogle Scholar
• 39 King D, Strynadka N. Crystal structure of New Delhi metallo-β-lactamase reveals molecular basis for antibiotic resistance. Protein Sci. 20(9), 1484–1491 (2011). • Crystal structure of uncomplexed NDM-1 at 2.1 Å resolution with a proposed mechanism of antibiotic resistance.
  Medline CASGoogle Scholar
• 40 Chen J, Chen H, Shi Y et al. Probing the effect of the nonactive-site mutation Y229W in New Delhi metallo-β-lactamase-1 by site-directed mutagenesis, kinetic studies and molecular dynamics simulations. PLoS ONE 8, e820–80 (2013).
  Google Scholar
• 41 Green VL, Verma A, Owens RJ, Phillips SE, Carr SB. Structure of New Delhi metallo-β-lactamase 1 (NDM-1). Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 67(Pt 10), 1160–1164 (2011).
  Medline CASGoogle Scholar
• 42 Toleman MA, Bennett PM, Walsh TR. ISCR elements: novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 70(2), 296–316 (2006).
  Medline CASGoogle Scholar
• 43 Concha NO, Rasmussen BA, Bush K, Herzberg O. Crystal structure of the wide-spectrum binuclear zinc beta-lactamase from Bacteroides fragilis. Structure 4(7), 823–836 (1996).
  Medline CASGoogle Scholar
• 44 King DT, Worrall LJ, Gruninger R, Strynadka NC. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition. J. Am. Chem. Soc. 134(28), 11362–11365 (2012).
  Medline CASGoogle Scholar
• 45 Wang Z, Fast W, Valentine AM, Benkovic SJ. Metallo-beta-lactamase: structure and mechanism. Curr. Opin. Chem. Biol. 3(5), 614–622 (1999).
  Medline CASGoogle Scholar
• 46 Zhu K, Lu J, Ye F et al. Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1. Biochem. Biophys. Res. Commun. 431(1), 2–7 (2013).
  Medline CASGoogle Scholar
• 47 Chen J, Chen H, Zhu T, Zhou D. Asp120Asn mutation impairs the catalytic activity of NDM-1 metallo-β-lactamase: experimental and computational study. Phys. Chem. Chem. Phys. 16(14), 6709–6716 (2014).
  Medline CASGoogle Scholar
• 48 Kazmierczak KM, Rabine S, Hackel M et al. Multiyear, multinational survey of the incidence and global distribution of metallo-β-lactamase-producing enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 60(2), 1067–1078 (2015).
  MedlineGoogle Scholar
• 49 Makena A, Brem J, Pfeffer I et al. Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability. J. Antimicrob. Chemother. 70(2), 463–469 (2015).
  Medline CASGoogle Scholar
• 50 Kaase M, Nordmann P, Wichelhaus TA et al. NDM-2 carbapenemase in Acinetobacter baumanii from Egypt. J. Antimicrob. Chemother. 66(6), 1260–1262 (2011).
  Medline CASGoogle Scholar
• 51 Khan AU, Rehman MT. Role of nonactive-site residue Trp-93 in the function and stability of New Delhi metallo-β-lactamase 1. Antimicrob. Agents Chemother. 60(1), 356–360 (2016).
  Medline CASGoogle Scholar
• 52 Groundwater PW, Xu S, Lai F et al. New Delhi metallo-β-lactamase-1: structure, inhibitors and detection of producers. Future Med. Chem. 8(9), 993–1012 (2016).
  CASGoogle Scholar
• 53 Khan AU, Maryam L, Zarrilli R. Structure, genetics and worldwide spread of New Delhi metallo-β-lactamase (NDM): a threat to public health. BMC Microbiol. 17(1), 101 (2017). • Gives comparative data of the 17 NDM variants.
  MedlineGoogle Scholar